Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 121.77 Million CNY | 11.82% |
| 2022 | 108.9 Million CNY | -25.95% |
| 2021 | 147.06 Million CNY | -28.82% |
| 2020 | 206.62 Million CNY | -30.45% |
| 2019 | 297.07 Million CNY | -17.13% |
| 2018 | 358.47 Million CNY | 103.23% |
| 2017 | 176.38 Million CNY | 42.56% |
| 2016 | 123.72 Million CNY | 30.56% |
| 2015 | 94.76 Million CNY | -36.28% |
| 2014 | 148.72 Million CNY | -47.16% |
| 2013 | 281.46 Million CNY | 22.87% |
| 2012 | 229.07 Million CNY | -17.38% |
| 2011 | 277.26 Million CNY | 18.37% |
| 2010 | 234.22 Million CNY | -4.53% |
| 2009 | 245.33 Million CNY | -3.4% |
| 2008 | 253.97 Million CNY | -4.24% |
| 2007 | 265.22 Million CNY | 2.14% |
| 2006 | 259.67 Million CNY | 8.78% |
| 2005 | 238.7 Million CNY | 13.83% |
| 2004 | 209.71 Million CNY | 6.66% |
| 2003 | 196.62 Million CNY | 24.26% |
| 2002 | 158.23 Million CNY | 9.56% |
| 2001 | 144.42 Million CNY | 53.39% |
| 2000 | 94.15 Million CNY | -31.66% |
| 1999 | 137.76 Million CNY | 6.65% |
| 1998 | 129.17 Million CNY | 36.69% |
| 1997 | 94.5 Million CNY | 27.49% |
| 1996 | 74.12 Million CNY | 12.53% |
| 1995 | 65.86 Million CNY | 15.91% |
| 1994 | 56.82 Million CNY | 32.27% |
| 1993 | 42.96 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 38.33 Million CNY | 7.46% |
| 2024 Q3 | 64.56 Million CNY | 102.94% |
| 2024 Q2 | 31.81 Million CNY | -17.01% |
| 2023 Q2 | 28.7 Million CNY | 28.98% |
| 2023 Q1 | 22.25 Million CNY | -27.31% |
| 2023 FY | 121.77 Million CNY | 11.82% |
| 2023 Q3 | 35.15 Million CNY | 22.48% |
| 2023 Q4 | 35.67 Million CNY | 1.47% |
| 2022 Q3 | 26.42 Million CNY | 2.38% |
| 2022 Q1 | 26.05 Million CNY | -44.86% |
| 2022 FY | 108.9 Million CNY | -25.95% |
| 2022 Q4 | 30.61 Million CNY | 15.84% |
| 2022 Q2 | 25.81 Million CNY | -0.92% |
| 2021 FY | 147.06 Million CNY | -28.82% |
| 2021 Q1 | 38.91 Million CNY | -16.34% |
| 2021 Q2 | 38.3 Million CNY | -1.58% |
| 2021 Q3 | 22.6 Million CNY | -40.98% |
| 2021 Q4 | 47.24 Million CNY | 109.0% |
| 2020 FY | 206.62 Million CNY | -30.45% |
| 2020 Q1 | 55.72 Million CNY | -28.72% |
| 2020 Q2 | 55.56 Million CNY | -0.27% |
| 2020 Q3 | 48.82 Million CNY | -12.14% |
| 2020 Q4 | 46.51 Million CNY | -4.73% |
| 2019 Q3 | 70.78 Million CNY | -2.24% |
| 2019 Q1 | 75.7 Million CNY | 10.93% |
| 2019 Q2 | 72.4 Million CNY | -4.36% |
| 2019 Q4 | 78.17 Million CNY | 10.45% |
| 2019 FY | 297.07 Million CNY | -17.13% |
| 2018 Q1 | 90.37 Million CNY | -1.65% |
| 2018 Q2 | 132.15 Million CNY | 46.24% |
| 2018 Q3 | 67.69 Million CNY | -48.78% |
| 2018 Q4 | 68.25 Million CNY | 0.82% |
| 2018 FY | 358.47 Million CNY | 103.23% |
| 2017 Q4 | 91.88 Million CNY | 136.99% |
| 2017 Q2 | 22 Million CNY | -7.25% |
| 2017 Q1 | 23.72 Million CNY | -48.47% |
| 2017 FY | 176.38 Million CNY | 42.56% |
| 2017 Q3 | 38.77 Million CNY | 76.23% |
| 2016 FY | 123.72 Million CNY | 30.56% |
| 2016 Q3 | 26.48 Million CNY | 1.21% |
| 2016 Q2 | 26.16 Million CNY | 4.5% |
| 2016 Q1 | 25.04 Million CNY | -5.42% |
| 2016 Q4 | 46.03 Million CNY | 73.81% |
| 2015 Q1 | 24.98 Million CNY | -30.32% |
| 2015 FY | 94.76 Million CNY | -36.28% |
| 2015 Q4 | 26.47 Million CNY | 6.94% |
| 2015 Q3 | 24.75 Million CNY | 33.5% |
| 2015 Q2 | 18.54 Million CNY | -25.78% |
| 2014 Q4 | 35.86 Million CNY | 31.39% |
| 2014 FY | 148.72 Million CNY | -47.16% |
| 2014 Q1 | 41.63 Million CNY | -45.8% |
| 2014 Q2 | 43.94 Million CNY | 5.54% |
| 2014 Q3 | 27.29 Million CNY | -37.89% |
| 2013 FY | 281.46 Million CNY | 22.87% |
| 2013 Q2 | 65.21 Million CNY | -13.39% |
| 2013 Q4 | 76.81 Million CNY | 19.73% |
| 2013 Q3 | 64.15 Million CNY | -1.63% |
| 2013 Q1 | 75.29 Million CNY | 20.16% |
| 2012 FY | 229.07 Million CNY | -17.38% |
| 2012 Q4 | 62.65 Million CNY | 20.04% |
| 2012 Q2 | 66.9 Million CNY | 41.41% |
| 2012 Q3 | 52.19 Million CNY | -21.99% |
| 2012 Q1 | 47.31 Million CNY | -35.82% |
| 2011 Q4 | 73.72 Million CNY | 11.61% |
| 2011 Q1 | 78.36 Million CNY | 17.84% |
| 2011 Q3 | 66.05 Million CNY | 11.73% |
| 2011 Q2 | 59.12 Million CNY | -24.55% |
| 2011 FY | 277.26 Million CNY | 18.37% |
| 2010 Q1 | 55.5 Million CNY | 5.5% |
| 2010 Q2 | 56.87 Million CNY | 2.46% |
| 2010 Q3 | 55.34 Million CNY | -2.68% |
| 2010 Q4 | 66.49 Million CNY | 20.15% |
| 2010 FY | 234.22 Million CNY | -4.53% |
| 2009 Q2 | 73.99 Million CNY | 9.26% |
| 2009 Q3 | 50.99 Million CNY | -31.08% |
| 2009 Q1 | 67.72 Million CNY | 11.9% |
| 2009 FY | 245.33 Million CNY | -3.4% |
| 2009 Q4 | 52.61 Million CNY | 3.17% |
| 2008 Q1 | 74.35 Million CNY | 12.81% |
| 2008 Q4 | 60.52 Million CNY | 17.83% |
| 2008 Q3 | 51.36 Million CNY | -24.17% |
| 2008 FY | 253.97 Million CNY | -4.24% |
| 2008 Q2 | 67.73 Million CNY | -8.91% |
| 2007 Q2 | 72.55 Million CNY | 6.01% |
| 2007 Q4 | 65.91 Million CNY | 13.01% |
| 2007 Q3 | 58.32 Million CNY | -19.61% |
| 2007 Q1 | 68.43 Million CNY | 16.38% |
| 2007 FY | 265.22 Million CNY | 2.14% |
| 2006 Q1 | 63.01 Million CNY | 3.41% |
| 2006 FY | 259.67 Million CNY | 8.78% |
| 2006 Q4 | 58.8 Million CNY | -12.01% |
| 2006 Q3 | 66.82 Million CNY | -5.9% |
| 2006 Q2 | 71.01 Million CNY | 12.7% |
| 2005 Q3 | 54.38 Million CNY | -15.34% |
| 2005 Q1 | 59.14 Million CNY | 3.69% |
| 2005 FY | 238.7 Million CNY | 13.83% |
| 2005 Q2 | 64.23 Million CNY | 8.61% |
| 2005 Q4 | 60.94 Million CNY | 12.06% |
| 2004 FY | 209.71 Million CNY | 6.66% |
| 2004 Q4 | 57.04 Million CNY | 8.99% |
| 2004 Q1 | 48.07 Million CNY | -13.63% |
| 2004 Q2 | 52.25 Million CNY | 8.7% |
| 2004 Q3 | 52.33 Million CNY | 0.15% |
| 2003 Q2 | 53.88 Million CNY | 19.86% |
| 2003 FY | 196.62 Million CNY | 24.26% |
| 2003 Q4 | 55.65 Million CNY | 32.16% |
| 2003 Q1 | 44.96 Million CNY | 18.85% |
| 2003 Q3 | 42.11 Million CNY | -21.85% |
| 2002 Q3 | 38.72 Million CNY | -1.58% |
| 2002 Q4 | 37.83 Million CNY | -2.32% |
| 2002 Q1 | 42.32 Million CNY | 7.85% |
| 2002 FY | 158.23 Million CNY | 9.56% |
| 2002 Q2 | 39.34 Million CNY | -7.04% |
| 2001 FY | 144.42 Million CNY | 53.39% |
| 2001 Q4 | 39.24 Million CNY | 9.72% |
| 2001 Q3 | 35.77 Million CNY | 0.0% |
| 2000 FY | 94.15 Million CNY | -31.66% |
| 1999 FY | 137.76 Million CNY | 6.65% |
| 1998 FY | 129.17 Million CNY | 36.69% |
| 1997 FY | 94.5 Million CNY | 27.49% |
| 1996 FY | 74.12 Million CNY | 12.53% |
| 1995 FY | 65.86 Million CNY | 15.91% |
| 1994 FY | 56.82 Million CNY | 32.27% |
| 1993 FY | 42.96 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 22.81 Billion CNY | 99.466% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 10.05 Billion CNY | 98.789% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 6.73 Billion CNY | 98.191% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 2.31 Billion CNY | 94.732% |
| Aurora Optoelectronics Co.,Ltd. | 327.9 Million CNY | 62.862% |
| NanJing Pharmaceutical Company Limited | 53.58 Billion CNY | 99.773% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.28 Billion CNY | 90.516% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 3.07 Billion CNY | 96.04% |